(Q35690164)

9 August 2017

1 reference

title

Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option (English)

1 reference

9 August 2017

main subject

urinary tract infection

1 reference

Joseph M Blondeau

1

1 reference

9 August 2017

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

64

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

611-628

1 reference

Epidemiology of urinary tract infections: incidence, morbidity, and economic costs

9 August 2017

cites work

1 reference

12 December 2020

EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU)

1 reference

12 December 2020

The safety profile of the fluoroquinolones.

1 reference

12 December 2020

The fluoroquinolone antibacterials: past, present and future perspectives

1 reference

12 December 2020

An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project

1 reference

12 December 2020

Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial

1 reference

12 December 2020

Urinary tract infection: traditional pharmacologic therapies

1 reference

12 December 2020

Pain rating by patients and physicians: evidence of systematic pain miscalibration

1 reference

12 December 2020

A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group

1 reference

12 December 2020

Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women

1 reference

12 December 2020

Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of fluoroquinolones

1 reference

12 December 2020

In vitro activity of BAY 12-8039, a new fluoroquinolone

1 reference

12 December 2020

Clinical use of the fluoroquinolones

1 reference

12 December 2020

A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection

1 reference

12 December 2020

Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsule

1 reference

12 December 2020

High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women

1 reference

12 December 2020

Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis

1 reference

12 December 2020

In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

1 reference

12 December 2020

Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis

1 reference

12 December 2020

Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network

1 reference

12 December 2020

Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections

1 reference

12 December 2020

Pharmacodynamics of fluoroquinolones.

1 reference

12 December 2020

Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.

1 reference

12 December 2020

A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group

1 reference

12 December 2020

Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case-control study with multivariate analysis for other risk factors

1 reference

12 December 2020

The etiology of urinary tract infection: traditional and emerging pathogens.

1 reference

12 December 2020

Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women

1 reference

12 December 2020

The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women

1 reference

12 December 2020

Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Prog

1 reference

12 December 2020

Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability

1 reference

12 December 2020

Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates

1 reference

12 December 2020

Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997.

1 reference

12 December 2020

Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States

1 reference

12 December 2020

Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).

1 reference

12 December 2020

Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998).

1 reference

12 December 2020

Fluoroquinolone antibiotics: properties of the class and individual agents

1 reference

12 December 2020

10.2165/00003495-200464060-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

9 August 2017

1023478442

0 references

1 reference